Data through FY2026 Q3 (Jun 30, 2026)
Rentschler Biopharma, Inc.
Company profile for Rentschler Biopharma, Inc. covers 8 filings across the reporting window. FY2026 certified median offer: $127,436.
- FY2026 certified median
- $127,436
- Total filings
- 8
- FY2026 25th–75th percentile
- $107,493–$161,368
- Top job title
- Director, CMC Project Management
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 1 | $140,000 | $140,000 | $140,000 |
| FY2025 | 4 | $129,225 | $115,875 | $140,625 |
| FY2026 (Q1–Q3) | 3 | $127,436 | $107,493 | $161,368 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Director, CMC Project Management1 filings
- Principal Scientist, Analytical Development1 filings
- Quality Assurance Associate, Data Reviewer1 filings
- Regulatory Affairs Manager1 filings
- Senior Scientist, QC Analytical1 filings
- Senior Stability Specialist1 filings
- Senior Validation Engineer1 filings
- VALIDATION ENGINEER1 filings
Top cities
- Milford8 filings